These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31231974)

  • 41. A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipation.
    Webster L; Dhar S; Eldon M; Masuoka L; Lappalainen J; Sostek M
    Pain; 2013 Sep; 154(9):1542-1550. PubMed ID: 23726675
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of naloxegol for opioid-induced constipation assessed by specific opioid medication, opioid dose, and duration of opioid use.
    Nalamachu S; Gudin J; Datto C; Coyne K; Poon JL; Hu Y
    J Opioid Manag; 2018; 14(3):211-221. PubMed ID: 30044486
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparing the effectiveness of magnesium oxide and naldemedine in preventing opioid-induced constipation: a proof of concept, single institutional, two arm, open-label, phase II, randomized controlled trial: the MAGNET study.
    Ozaki A; Kessoku T; Iwaki M; Kobayashi T; Yoshihara T; Kato T; Honda Y; Ogawa Y; Imajo K; Higurashi T; Yoneda M; Taguri M; Yamanaka T; Ishiki H; Kobayashi N; Saito S; Ichikawa Y; Nakajima A
    Trials; 2020 Jun; 21(1):453. PubMed ID: 32487150
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Bowel Function Index: a new validated scale for assessing opioid-induced constipation.
    Ducrotté P; Caussé C
    Curr Med Res Opin; 2012 Mar; 28(3):457-66. PubMed ID: 22236136
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Opioid-induced constipation negatively impacts pain management, productivity, and health-related quality of life: findings from the National Health and Wellness Survey.
    Bell T; Annunziata K; Leslie JB
    J Opioid Manag; 2009; 5(3):137-44. PubMed ID: 19662923
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fixed ratio (2:1) prolonged-release oxycodone/naloxone combination improves bowel function in patients with moderate-to-severe pain and opioid-induced constipation refractory to at least two classes of laxatives.
    Koopmans G; Simpson K; De Andrés J; Lux EA; Wagemans M; Van Megen Y
    Curr Med Res Opin; 2014 Nov; 30(11):2389-96. PubMed ID: 25265132
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization and Associated Costs of Constipation Relating to Exposure to Strong Opioids in England: An Observational Study.
    Morgan CL; Jenkins-Jones S; Knaggs R; Currie C; Conway P; Poole CD; Berni E
    Clin Ther; 2021 Jun; 43(6):968-989. PubMed ID: 33931241
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence and Risk Factors for Opioid-Induced Constipation in an Older National Veteran Cohort.
    FitzHenry F; Eden SK; Denton J; Cao H; Cao A; Reeves R; Chen G; Gobbel G; Wells N; Matheny ME
    Pain Res Manag; 2020; 2020():5165682. PubMed ID: 32318129
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Opioid-Induced Constipation in Oncological Patients: New Strategies of Management.
    Mesía R; Virizuela Echaburu JA; Gómez J; Sauri T; Serrano G; Pujol E
    Curr Treat Options Oncol; 2019 Dec; 20(12):91. PubMed ID: 31853656
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Side effects from opioids used for acute pain after emergency department discharge.
    Daoust R; Paquet J; Cournoyer A; Piette É; Morris J; Lessard J; Castonguay V; Williamson D; Chauny JM
    Am J Emerg Med; 2020 Apr; 38(4):695-701. PubMed ID: 31182367
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of naldemedine for the treatment of opioid-induced constipation: A meta-analysis.
    Esmadi M; Ahmad D; Hewlett A
    J Gastrointestin Liver Dis; 2019 Mar; 28(1):41-46. PubMed ID: 30851171
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A New Twist on the Administration of Naldemedine for Opioid-Induced Constipation in an Outpatient].
    Shikada Y; Emi Y; Kometani T; Ochiai T; Fujii M; Noda Y; Kajiwara M; Ikeda M; Asonuma S; Mori M
    Gan To Kagaku Ryoho; 2018 Jul; 45(7):1075-1079. PubMed ID: 30042276
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study.
    Mori M; Ji Y; Kumar S; Ashikaga T; Ades S
    Int J Clin Oncol; 2017 Apr; 22(2):397-404. PubMed ID: 27628064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Opioid-Induced Constipation Survey in Patients with Chronic Noncancer Pain.
    Rauck RL; Hong KJ; North J
    Pain Pract; 2017 Mar; 17(3):329-335. PubMed ID: 26990277
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation.
    Webster L; Chey WD; Tack J; Lappalainen J; Diva U; Sostek M
    Aliment Pharmacol Ther; 2014 Oct; 40(7):771-9. PubMed ID: 25112584
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Satisfaction with Therapy Among Patients with Chronic Noncancer Pain with Opioid-Induced Constipation.
    LoCasale RJ; Datto C; Margolis MK; Coyne KS
    J Manag Care Spec Pharm; 2016 Mar; 22(3):246-53. PubMed ID: 27003554
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reliability and validity of the Bowel Function Index for evaluating opioid-induced constipation: translation, cultural adaptation and validation of the Portuguese version (BFI-P).
    Dueñas M; Mendonça L; Sampaio R; Gouvinhas C; Oliveira D; Castro-Lopes JM; Azevedo LF
    Curr Med Res Opin; 2017 Mar; 33(3):563-572. PubMed ID: 27981871
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patient preference with respect to QoL and reduction in opioid-induced constipation (OIC) after treatment with prolonged-release (PR) oxycodone/naloxone compared with previous analgesic therapy [PREFER study].
    van Dongen VC; Vanelderen PJ; Koopmans-Klein G; van Megen YJ; Van Zundert J; Huygen FJ
    Int J Clin Pract; 2014 Nov; 68(11):1364-75. PubMed ID: 24853258
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction-Recommendations of the Nordic Working Group.
    Drewes AM; Munkholm P; Simrén M; Breivik H; Kongsgaard UE; Hatlebakk JG; Agreus L; Friedrichsen M; Christrup LL
    Scand J Pain; 2016 Apr; 11():111-122. PubMed ID: 28850449
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Opioid-induced constipation, use of laxatives, and health-related quality of life.
    Christensen HN; Olsson U; From J; Breivik H
    Scand J Pain; 2016 Apr; 11():104-110. PubMed ID: 28850447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.